S.22 (Act 61)
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration
Sponsors:
Sen. Virginia Lyons
,
Sen. Richard McCormack
Last Recorded Action: 5/21/2021 - Senate Message, signed by Governor <strong>June 7, 2021</strong>
Committee Activity - Witnesses Who Testified
Regular Session 2021-2022
House Committee on Health Care
- Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office
- Jessa Barnard, Executive Director, Vermont Medical Society
- Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- David Herlihy, Executive Director, Vermont Board of Medical Practice
- Lauren Hibbert, Director, Office of Professional Regulation, Secretary of State's Office
- Sen. Cheryl Hooker, Reporter, Senate Health and Welfare
- Sam Russo, Vermont Association of Naturopathic Physicians
- Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont
Senate Committee on Health and Welfare
- Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office
- Jessa Barnard, Executive Director, Vermont Medical Society
- Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- David Herlihy, Executive Director, Vermont Board of Medical Practice
- Sen. Virginia "Ginny" Lyons, Sponsor, Chittenden County
- Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont